Stephen Taub Premium An Under-the-Radar Hedge Fund Reaps Big IPO Rewards Bihua Chen’s Cormorant Asset Management is scoring big gains from development stage biopharma companies. Stephen Taub December 17, 2020 Bihua Chen, CEO of Cormorant Asset Management. (Alex Flynn/Bloomberg)